GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AbbVie Inc (BSP:ABBV34) » Definitions » Cyclically Adjusted PB Ratio

AbbVie (BSP:ABBV34) Cyclically Adjusted PB Ratio : 48.11 (As of Jun. 03, 2025)


View and export this data going back to 2016. Start your Free Trial

What is AbbVie Cyclically Adjusted PB Ratio?

As of today (2025-06-03), AbbVie's current share price is R$66.39. AbbVie's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was R$1.38. AbbVie's Cyclically Adjusted PB Ratio for today is 48.11.

The historical rank and industry rank for AbbVie's Cyclically Adjusted PB Ratio or its related term are showing as below:

BSP:ABBV34' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 33.47   Med: 44.96   Max: 57.36
Current: 48.94

During the past years, AbbVie's highest Cyclically Adjusted PB Ratio was 57.36. The lowest was 33.47. And the median was 44.96.

BSP:ABBV34's Cyclically Adjusted PB Ratio is ranked worse than
99.42% of 693 companies
in the Drug Manufacturers industry
Industry Median: 1.94 vs BSP:ABBV34: 48.94

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

AbbVie's adjusted book value per share data for the three months ended in Mar. 2025 was R$0.289. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is R$1.38 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


AbbVie Cyclically Adjusted PB Ratio Historical Data

The historical data trend for AbbVie's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AbbVie Cyclically Adjusted PB Ratio Chart

AbbVie Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 44.43 45.74 50.43 41.86 46.62

AbbVie Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.11 45.19 52.00 46.62 54.38

Competitive Comparison of AbbVie's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - General subindustry, AbbVie's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AbbVie's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AbbVie's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where AbbVie's Cyclically Adjusted PB Ratio falls into.


;
;

AbbVie Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

AbbVie's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=66.39/1.38
=48.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AbbVie's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, AbbVie's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.289/134.9266*134.9266
=0.289

Current CPI (Mar. 2025) = 134.9266.

AbbVie Quarterly Data

Book Value per Share CPI Adj_Book
201506 0.647 100.684 0.867
201509 0.726 100.392 0.976
201512 0.594 99.792 0.803
201603 0.663 100.470 0.890
201606 0.741 101.688 0.983
201609 0.809 101.861 1.072
201612 0.610 101.863 0.808
201703 0.614 102.862 0.805
201706 0.777 103.349 1.014
201709 0.820 104.136 1.062
201712 0.659 104.011 0.855
201803 0.459 105.290 0.588
201806 -0.525 106.317 -0.666
201809 -0.499 106.507 -0.632
201812 -1.386 105.998 -1.764
201903 -1.271 107.251 -1.599
201906 -1.396 108.070 -1.743
201909 -1.432 108.329 -1.784
201912 -1.418 108.420 -1.765
202003 -1.533 108.902 -1.899
202006 2.703 108.767 3.353
202009 2.919 109.815 3.586
202012 2.382 109.897 2.925
202103 2.735 111.754 3.302
202106 2.236 114.631 2.632
202109 2.529 115.734 2.948
202112 3.080 117.630 3.533
202203 2.866 121.301 3.188
202206 2.615 125.017 2.822
202209 2.964 125.227 3.194
202212 3.197 125.222 3.445
202303 2.450 127.348 2.596
202306 2.212 128.729 2.319
202309 2.114 129.860 2.196
202312 1.797 129.419 1.873
202403 1.411 131.776 1.445
202406 1.292 132.554 1.315
202409 1.181 133.029 1.198
202412 0.718 133.157 0.728
202503 0.289 134.927 0.289

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


AbbVie  (BSP:ABBV34) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


AbbVie Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of AbbVie's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


AbbVie Business Description

Address
1 North Waukegan Road, North Chicago, IL, USA, 60064-6400
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).

AbbVie Headlines

No Headlines